Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy

Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine : results from a population-based prospective cohort in Catalonia, Spain, 2020

Vivanco-Hidalgo, Rosa Maria
Molina, Israel
Martinez, Elisenda
Roman-Viñas, Ramón
Sánchez-Montalvá, Adrián
Fibla, Joan
Pontes, Caridad
Velasco Muñoz, César

Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine...

Determinants of cardiac adverse events of chloroquine and hydroxychloroquine in 20 years of drug safety surveillance reports

Cohen, Isaac
Makunts, Tigran
Moumedjian, Talar
Issa, Masara
Abagyan, Ruben

January 2020

Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization’s List of Essenti...

Revisiting the cardiovascular risk of hydroxychloroquine in RA

Pers, Yves-Marie
Padern, Guillaume

December 2020

International audienceCardiac toxicity can be induced by hydroxychloroquine, especially when used in...

Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy

Alegiani, Stefania Spila
Crisafulli, Salvatore
Rossi, Paolo Giorgi
Mancuso, Pamela
Salvarani, Carlo
Atzeni, Fabiola
Gini, Rosa
Kirchmayer, Ursula
Belleudi, Valeria
Kurotschka, Peter Konstantin
Leoni, Olivia
Ludergnani, Monica
Ferroni, Eliana
Baracco, Susanna
Massari, Marco
Trifirò, Gianluca

January 2021

To ascertain if hydroxychloroquine (HCQ)/chloroquine (CLQ) and other conventional disease-modifying ...

COVID-19, hydroxychloroquine and sudden cardiac death: Implications for clinical practice in patients with rheumatic diseases

Raza, Hussain Ahmed
Tariq, Javeria
Agarwal, Vikas
Gupta, Latika

February 2021

Sudden cardiac death is commonly seen due to arrhythmias, which is a common cardiac manifestation se...

Juan Macías
Paz González-Moreno
Esther Sánchez-García
Ramón Morillo-Verdugo
José J Pérez-Venegas
Ana Pinilla
MªMar Macho
MªVictoria Martínez
Alejandro González-Serna
Anaïs Corma
Luis M Real
Juan A Pineda

January 2021

BackgroundHydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus dis...

COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis

Isabela Landsteiner de Sampaio Amêndola
Jonathan Aires Pinheiro
Pedro Póvoa
Vicente Cés de Souza Dantas
Rodrigo Bernardo Serafim

November 2022

The ongoing chronic use of hydroxychloroquine or chloroquine (HCQ/CQ) in rheumatic patients might im...

Cardio-Vascular Complications of Hydroxychloroquine Use: Can Impact COVID-19 Pandemic

Taruna Singh
Rakshit Arora
Amrit Sharma

June 2020

As the coronavirus pandemic is on the rise, many compounds with anti-viral properties are under inve...

Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.

Yazdany, Jinoos
Kim, Alfred HJ

June 2020

Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chlor...

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Castelnuovo A. D.
Costanzo S.
Antinori A.
Berselli N.
Blandi L.
Bruno R.
Cauda R.
Guaraldi G.
Menicanti L.
My I.
Parruti G.
Patti G.
Perlini S.
Santilli F.
Signorelli C.
Spinoni E.
Stefanini G. G.
Vergori A.
Ageno W.
Agodi A.
Aiello L.
Agostoni P.
Moghazi S. A.
Astuto M.
Aucella F.
Barbieri G.
Bartoloni A.
Bonaccio M.
Bonfanti P.
Cacciatore F.
Caiano L.
Cannata F.
Carrozzi L.
Cascio A.
Ciccullo A.
Cingolani A.
Cipollone F.
Colomba C.
Crosta F.
Pra C. D.
Danzi G. B.
D'Ardes D.
Donati K. D. G.
Giacomo P. D.
Gennaro F. D.
Di Tano G.
D'Offizi G.
Filippini T.
Fusco F. M.
Gentile I.
Gialluisi A.
Gini G.
Grandone E.
Grisafi L.
Guarnieri G.
Lamonica S.
Landi F.
Leone A.
Maccagni G.
Maccarella S.
Madaro A.
Mapelli M.
Maragna R.
Marra L.
Maresca G.
Marotta C.
Mastroianni F.
Mazzitelli M.
Mengozzi A.
Menichetti F.
Meschiari M.
Minutolo F.
Montineri A.
Mussinelli R.
Mussini C.
Musso M.
Odone A.
Olivieri M.
Pasi E.
Petri F.
Pinchera B.
Pivato C. A.
Poletti V.
Ravaglia C.
Rinaldi M.
Rognoni A.
Rossato M.
Rossi I.
Rossi M.
Sabena A.
Salinaro F.
Sangiovanni V.
Sanrocco C.
Scorzolini L.
Sgariglia R.
Simeone P. G.
Spinicci M.
Trecarichi E. M.
Venezia A.
Veronesi G.
Vettor R.
Vianello A.
Vinceti M.
Vocciante L.
De Caterina R.
Iacoviello L.

January 2020

Background: Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. Objective: We...

Cardio-Vascular Complications of Hydroxychloroquine Use: Can Impact COVID-19 Pandemic

Taruna Singh
Rakshit Arora
Amrit Sharma

June 2020

As the coronavirus pandemic is on the rise, many compounds with anti-viral properties are under inve...

Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study

Sarzi-Puttini P.
Marotto D.
Caporali R.
Montecucco C. M.
Favalli E. G.
Franceschini F.
Fredi M.
Balduzzi S.
Bazzani C.
Bongiovanni S.
Giorgi V.
Batticciotto A.
Cappelli A.
Balzarini P.
Dagna L.
Sartorelli S.
Ravagnani V.
Tamanini S.
Farah S.
Faggioli P.
Castelnovo L.
Lurati A. M.
Galli M.
Salaffi F.

January 2021

Objective: The COVID-19 pandemic has raised questions about the management of systemic immunosuppres...

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.

Michael J Satlin
Parag Goyal
Reed Magleby
Grace A Maldarelli
Khanh Pham
Maiko Kondo
Edward J Schenck
Hanna Rennert
Lars F Westblade
Justin J Choi
Monika M Safford
Roy M Gulick

January 2020

BackgroundSevere acute respiratory coronavirus 2 (SARS-CoV-2) has caused a devastating worldwide pan...

Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine : results from a population-based prospective cohort in Catalonia, Spain, 2020

Vivanco-Hidalgo, Rosa Maria
Molina, Israel
Martinez, Elisenda
Roman-Viñas, Ramón
Sánchez-Montalvá, Adrián
Fibla, Joan
Pontes, Caridad
Velasco Muñoz, César

Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine...

Determinants of cardiac adverse events of chloroquine and hydroxychloroquine in 20 years of drug safety surveillance reports

Cohen, Isaac
Makunts, Tigran
Moumedjian, Talar
Issa, Masara
Abagyan, Ruben

January 2020

Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization’s List of Essenti...

Revisiting the cardiovascular risk of hydroxychloroquine in RA

Pers, Yves-Marie
Padern, Guillaume

December 2020

International audienceCardiac toxicity can be induced by hydroxychloroquine, especially when used in...

Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy

Alegiani, Stefania Spila
Crisafulli, Salvatore
Rossi, Paolo Giorgi
Mancuso, Pamela
Salvarani, Carlo
Atzeni, Fabiola
Gini, Rosa
Kirchmayer, Ursula
Belleudi, Valeria
Kurotschka, Peter Konstantin
Leoni, Olivia
Ludergnani, Monica
Ferroni, Eliana
Baracco, Susanna
Massari, Marco
Trifirò, Gianluca

January 2021

To ascertain if hydroxychloroquine (HCQ)/chloroquine (CLQ) and other conventional disease-modifying ...

COVID-19, hydroxychloroquine and sudden cardiac death: Implications for clinical practice in patients with rheumatic diseases

Raza, Hussain Ahmed
Tariq, Javeria
Agarwal, Vikas
Gupta, Latika

February 2021

Sudden cardiac death is commonly seen due to arrhythmias, which is a common cardiac manifestation se...

Juan Macías
Paz González-Moreno
Esther Sánchez-García
Ramón Morillo-Verdugo
José J Pérez-Venegas
Ana Pinilla
MªMar Macho
MªVictoria Martínez
Alejandro González-Serna
Anaïs Corma
Luis M Real
Juan A Pineda

January 2021

BackgroundHydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus dis...

COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis

Isabela Landsteiner de Sampaio Amêndola
Jonathan Aires Pinheiro
Pedro Póvoa
Vicente Cés de Souza Dantas
Rodrigo Bernardo Serafim

November 2022

The ongoing chronic use of hydroxychloroquine or chloroquine (HCQ/CQ) in rheumatic patients might im...

Cardio-Vascular Complications of Hydroxychloroquine Use: Can Impact COVID-19 Pandemic

Taruna Singh
Rakshit Arora
Amrit Sharma

June 2020

As the coronavirus pandemic is on the rise, many compounds with anti-viral properties are under inve...

Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.

Yazdany, Jinoos
Kim, Alfred HJ

June 2020

Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chlor...

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Castelnuovo A. D.
Costanzo S.
Antinori A.
Berselli N.
Blandi L.
Bruno R.
Cauda R.
Guaraldi G.
Menicanti L.
My I.
Parruti G.
Patti G.
Perlini S.
Santilli F.
Signorelli C.
Spinoni E.
Stefanini G. G.
Vergori A.
Ageno W.
Agodi A.
Aiello L.
Agostoni P.
Moghazi S. A.
Astuto M.
Aucella F.
Barbieri G.
Bartoloni A.
Bonaccio M.
Bonfanti P.
Cacciatore F.
Caiano L.
Cannata F.
Carrozzi L.
Cascio A.
Ciccullo A.
Cingolani A.
Cipollone F.
Colomba C.
Crosta F.
Pra C. D.
Danzi G. B.
D'Ardes D.
Donati K. D. G.
Giacomo P. D.
Gennaro F. D.
Di Tano G.
D'Offizi G.
Filippini T.
Fusco F. M.
Gentile I.
Gialluisi A.
Gini G.
Grandone E.
Grisafi L.
Guarnieri G.
Lamonica S.
Landi F.
Leone A.
Maccagni G.
Maccarella S.
Madaro A.
Mapelli M.
Maragna R.
Marra L.
Maresca G.
Marotta C.
Mastroianni F.
Mazzitelli M.
Mengozzi A.
Menichetti F.
Meschiari M.
Minutolo F.
Montineri A.
Mussinelli R.
Mussini C.
Musso M.
Odone A.
Olivieri M.
Pasi E.
Petri F.
Pinchera B.
Pivato C. A.
Poletti V.
Ravaglia C.
Rinaldi M.
Rognoni A.
Rossato M.
Rossi I.
Rossi M.
Sabena A.
Salinaro F.
Sangiovanni V.
Sanrocco C.
Scorzolini L.
Sgariglia R.
Simeone P. G.
Spinicci M.
Trecarichi E. M.
Venezia A.
Veronesi G.
Vettor R.
Vianello A.
Vinceti M.
Vocciante L.
De Caterina R.
Iacoviello L.

January 2020

Background: Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. Objective: We...

Cardio-Vascular Complications of Hydroxychloroquine Use: Can Impact COVID-19 Pandemic

Taruna Singh
Rakshit Arora
Amrit Sharma

June 2020

As the coronavirus pandemic is on the rise, many compounds with anti-viral properties are under inve...

Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study

Sarzi-Puttini P.
Marotto D.
Caporali R.
Montecucco C. M.
Favalli E. G.
Franceschini F.
Fredi M.
Balduzzi S.
Bazzani C.
Bongiovanni S.
Giorgi V.
Batticciotto A.
Cappelli A.
Balzarini P.
Dagna L.
Sartorelli S.
Ravagnani V.
Tamanini S.
Farah S.
Faggioli P.
Castelnovo L.
Lurati A. M.
Galli M.
Salaffi F.

January 2021

Objective: The COVID-19 pandemic has raised questions about the management of systemic immunosuppres...

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.

Michael J Satlin
Parag Goyal
Reed Magleby
Grace A Maldarelli
Khanh Pham
Maiko Kondo
Edward J Schenck
Hanna Rennert
Lars F Westblade
Justin J Choi
Monika M Safford
Roy M Gulick

January 2020

BackgroundSevere acute respiratory coronavirus 2 (SARS-CoV-2) has caused a devastating worldwide pan...

Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine : results from a population-based prospective cohort in Catalonia, Spain, 2020

Vivanco-Hidalgo, Rosa Maria
Molina, Israel
Martinez, Elisenda
Roman-Viñas, Ramón
Sánchez-Montalvá, Adrián
Fibla, Joan
Pontes, Caridad
Velasco Muñoz, César

Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine...

Determinants of cardiac adverse events of chloroquine and hydroxychloroquine in 20 years of drug safety surveillance reports

Cohen, Isaac
Makunts, Tigran
Moumedjian, Talar
Issa, Masara
Abagyan, Ruben

January 2020

Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization’s List of Essenti...

Revisiting the cardiovascular risk of hydroxychloroquine in RA

Pers, Yves-Marie
Padern, Guillaume

December 2020

International audienceCardiac toxicity can be induced by hydroxychloroquine, especially when used in...

Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy

Abstract

Extracted data

Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy

Abstract

Extracted data

Related items

Related items